Fate Therapeutics Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Fate Therapeutics Inc.

Fate Therapeutics Inc. | Key People and Executives

J. Scott Wolchko

President, Chief Executive Officer & Director

Michael Stewart Lee

Director

John D. Mendlein

Vice Chairman

William H. Rastetter

Chairman

Robert S. Epstein

Independent Director

Amir H. Nashat

Independent Director

Timothy P. Coughlin

Independent Director

J. Scott Wolchko

President, Chief Executive Officer & Director

Chris M. Storgard

Chief Medical Officer

Daniel D. Shoemaker

Chief Scientific Officer

Jim Beitel

Senior Vice President-Corporate Development

Michael Stewart Lee

Director

John D. Mendlein

Vice Chairman

Cindy R. Tahl

Secretary & General Counsel

Moya M. Daniels

VP-Regulatory Affairs & Quality Assurance

William H. Rastetter

Chairman

Robert S. Epstein

Independent Director

Amir H. Nashat

Independent Director

Timothy P. Coughlin

Independent Director

View Profile

Address	3535 General Atomics Court San Diego California 92121 United States
Employees	-
Website	http://www.fatetherapeutics.com
Updated	07/08/2019
Fate Therapeutics, Inc. is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorder. It programmed cellular therapeutics for the treatment of life threatening diseases, hematologic malignancies, genetic disorders and diseases resulting from the dysregulation of the immune system. The company products include ProHema, ProTmune, Adaptive NK, iPSC-derived NK, Programmed CD34 and T cell therapy.